Derivatives of melphalan designed to enhance drug accumulation in cancer cells

Journal of Drug Targeting

Volumn 4, Issue 6, 1997, Pages 359-370

  Kupczyk Subotkowska, Lidia ^a   Tamura, Kiyoshi ^a   Pal, Dhananjay ^a   Sakaeda, Toshiyuki ^b   Siahaan, Teruna J ^a   Stella, Valentino J ^a   Borchardt, Ronald T ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b SHIONOGI AND CO LTD   (Japan)

Author keywords

Dipeptide derivatives; Esters; Melphalan; Prodrugs

Indexed keywords

CYTOTOXIC AGENT; DIPEPTIDE DERIVATIVE; MELPHALAN;

ANIMAL CELL; ARTICLE; CANCER CELL; CELL STRAIN CACO 2; CELL SURVIVAL; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; DIFFUSION; DRUG ACCUMULATION; DRUG DESIGN; DRUG UPTAKE; GLIOMA; HUMAN; HUMAN CELL; LIPOPHILICITY; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030789799     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/10611869709017893     Document Type: Article

References (35)

1. Begleiter, A., Lam, H.-I.P., Grover, J., Froese, E. and Goldenberg, G.J. (1979) Evidence for active transport of melphalan by two amino acid carriers in L5I78Y lymphoblasl in vitro. Cancer Res., 39, 353-359.
2. BergeL, R, Johnson, J.M. and Wade, R. (1962) Cyto-active aminoacids and peptides. Part IX. Further studies of N-acyl-dipeptides from Melphalan J. Chem. Sac., 3802-3805.
3. Bergel, F. and Stock, J.A. (1954) Cyto-active amino-acid and peptide derivatives. Part I. Substituted phenylalanines. J. Chem. Soc., 2409-2417.
4. Bergel, F. and Stock, J.A (1959) Cyto-active amino-acids and peptides. Part V. Derivatives of p-amino- and p-mercapto-phenylalanine. J. Chem. Soc., 90-96.
5. Boyd, C.A.R. and Yudilevich, D.L. (1987) Blood-tissue movement of amino acids in various organs: the basolateral membrane and its importance in the polarity of transepithelial transport. In Yudilevich, D. L., Boyd, C.A.R. (eds), Amino Acid Transport in Animal Cells (Manchester Manchester University Press), pp. 120-176.
6. Broer, S., Broer, A. and Hamprecht, B (1994) Expression of Na+-independent isoleucine transport activity from rat brain in Xenopus laevis oocytes. Biochim. Biophys. Acta, 1192, 95-100.
7. Chikhale, PJ. and Borchardt, R.T. (1994) Metabolism of L-α-raethyldopa in cultured human intestinal epithelial (Caco-2) cell monolayers. Comparison with metabolism in vivo. Drug Metab. Disp., 22, 592-600.
8. Cornford, E. M., Young, D., Paxton, J. W., Finlay, G. J. and Wilson, W. R, (1992) Melphalan penetration of the blood-brain barrier via the neutral amino acid transporter in tumor-bearing brain. Cancer Res., 52, 138-143.
9. Dantzig, A.H. and Bergin, L. (1988) Carrier-mediated uptake of cephalexin in human intestinal cells. Biochem. Biophys. Res. Commun., 155, 1082-1087.
10. Dantzig, A.H., Tabas, L.B. and Bergin, L. (1992) Cefaclor uptake by the proton-dependent dipeptide transport carrier of human intestinal Caco-2 cells and comparison to cephalexin uptake. Biochim. Biophys. Acta, 1112, 167-173.
11. Fairman, W.A., Vandenberg, R.J., Arriza, J.L., Kavanaugh, M.P. and Araara, S.G (1995) An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature, 375, 599-603.
12. Fei, Y.-J., Kanai, Y., Nussberger, S., Ganapathy, V., Leibach, F.H., Romero, M.F., Singh, S.K., Boron, W.F. and Hediger, MA. (1994) Expression cloning of a mammalian proton-coupled oligopeptide transporter. Nature, 368, 563-566.
13. Fisher, B., Carbone, P. and Economons, S.L. (1975) Phenylalanine mustard in the management of primary breast cancer. N. Engl. J. Med., 292, 117-122.
14. Friend, D.R. and Pangbum, S. (1987) Site-specific drug delivery. Med. Res. Rev., 7, 53-106.
15. George, R., Doth, J, and Duncan, G. (1977) Multiple myeloma intermittent combination chemotherapy compared to continuous therapy. Cancer, 29, 1665-1670.
16. Goldenberg, G.J., Lam, H.-Y.P. and Begleiter, A. (1979) Active carrier-mediated transport of melphalan by two separate amino acid transport systems in LPC-1 plasmacytoma cells in vitro, J. Biol. Chem., 254, 1057-1064.
17. Goldenberg, GJ., Lee, M., Lam, H.-Y.P. and Begleiter, A. (1977) Evidence for carrier-mediated transport of melphalan by L5178Y lymphoblasts in vitro. Cancer Res., 37, 755-760.
18. Greig, N.H., Momma, S., Sweeney, D.J., Smith, Q.R. and Rapoport, S.I. (1987) Facilitated transport of melphalan at the rat blood-brain barrier by the large neutral amino acid carrier system. Cancer Res., 47, 1571-1576.
19. Hidalgo. I.J. and Borchardt, R.T. (1990) Transport of a large neutral amino acid (phenylalanine) in a human intestinal cell line: Caco-2. Biochim. Biophys. Acta, 1028, 25-30.
20. Hidalgo, I.J., Raub, T.J. and Borchardt, R.T. (1989) Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology, 96, 736-749.
21. Hu, M. and Borchardt, R.T. (1990) Mechanism of L-α-methyldopa transport through a monolayer of polarized human intestinal epithelial cells (Caco-2), Pharm. Res., 7, 1313-1319.
22. Johnson, J.M. and Stock, J.A. ( 1962) Cyto-active arnino-acids and peptides. Part X. A pentapeptide and a basic dipeptide from melphalan. J. Chem. Soc., 3806-3808.
23. Larionov, I.F., Khokhlov, A.S., Shkodinskaja, E.N., Vasina, O.S., Troosheikina, V.l. and Novikova, M.A. (1955) Studies on the anti-tumor activity of p-di-(2-chloroethyl)aminophenylalanine (sarcolysme). Lancet, 23, 169-171.
24. McEvoy G.K., (ed). (1996) AHFS Drug Information 96, American Hospital Formulary Service, pp 746-749.
25. Mosmann, T. (1983) Rapid coloritmerric assay for cellular growth and survival: Application to proliferation and cytotoxicity assay. J. Immunol. Meth., 65, 55-63.
26. Piver, M., Barlow, J. and Lee, F. (1975) Sequential therapy for advanced ovarian carcinoma: operation, chemotherapy, second look laparotomy, and radiation therapy. Am. J. Obstet. Gynecol., 122, 355-357.
27. Saito, H. and Inui, K. (1993) Dipeptide transporters in apical and basolateral membranes of the human intestinal cell line Caco-2. Am. J. Physiol., 265, G 289-294.
28. Sakaeda, T., Tada, Y., Sugawara, T., Ryu, T., Hirose, F., Yoshikawa, T., Hirano, K., Kupczyk-Subotkowska, L., Siahaan, T.J., Audus, K.L. and Stella, V.J. (1996) Conjugation with L-glutamic acid for brain drug delivery. Proc. Int. Symp. Control. Release Bioact. Mater., 23, in press.
29. Tamura, K., Bhatnagar, P.K., Takata, J.S., Lee, C.-P., Smith, P.L. and Borchardt, R.T. (1996a) Metabolism, uptake and transepithelial transport of the diastereomers of Val-Val in the human intestinal cell line, Caco-2. Pharm. Res., 13, 1222-1227.
30. Tamura, K., Lee, C.P., Smith, P.L. and Borchardt, R.T. (1996b) Metabolism, uptake and transepithelial transport of the stereoisomers of Val-Val-Val in the human intestinal cell line, Caco-2. Pharm. Res., 13, 1661-1665.
31. +-coupled carriers at both apical and basolateral membranes. J. Biol. Chem., 268, 7640-7642.
32. + symport in intact human intestinal (Caco-2) epithelium - A novel method utilizing continuous intracellular pH measurement. Biochem. Biophyi. Res. Commun., 194, 432-408.
33. Vistica, D.T., Toal, J.N. and Rabinovitz, M. (1978) Amino acid-conferred protection against melphalan. Biochem. Pharmacol., 27, 2865-2870.
34. Vistica, D.T. (1979) Cytotoxicity as an indicator for transport mechanism. Biochim. Biophys. Acta, 550, 309-317.
35. Wessel, D. and Flugge. U.I. (1984). A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal. Biochem., 138, 141-143.